Ep.4 Sam Banister - Chief Science Officer at Psylo | Psychedelics, Biotech, Drug Dev, Startups and New TGA Reform

08/02/2023 52 min Temporada 1 Episodio 4
Ep.4 Sam Banister - Chief Science Officer at Psylo | Psychedelics, Biotech, Drug Dev, Startups and New TGA Reform

Listen "Ep.4 Sam Banister - Chief Science Officer at Psylo | Psychedelics, Biotech, Drug Dev, Startups and New TGA Reform"

Episode Synopsis

In this episode I chat with Sam Banister, the Chief Science Officer at Psylo. Psylo is an Australian biotechnology startup that is developing novel, psychedelic inspired molecules to treat various brain issues.We discuss all things psychedelics, biotech, drug development, building companies, mental health issues, the new TGA reform to reschedule MDMA and Psilocybin in Australia and much more.

More episodes of the podcast Futureneering